Paracrine/autocrine control of the islet and the amylin family.
Smith
D M
DM
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
Bloom
S R
SR
D000682:Amyloid / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D053379:Chromogranin A; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis; D006728:Hormones / Q000502:physiology*; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D058228:Islet Amyloid Polypeptide; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D009478:Neuropeptide Y / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology; D010187:Pancreatic Hormones / Q000494:pharmacology
D000682:Amyloid; D053379:Chromogranin A; D006728:Hormones; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D009478:Neuropeptide Y; D010187:Pancreatic Hormones; C050836:pancreastatin; D005947:Glucose